Here is where you'll find all the latest updates from The Eve Appeal; from research updates within the national media, to awareness and fundraising examples of our amazing supporters, both in national and regional media.
Eve Appeal ambassador and skincare expert Caroline Hirons tells Get The Gloss why she’s championing our Get Lippy campaign, how a smear test could’ve made all the difference to her grandma and why it’s time we all got comfortable with talking about all things gynae-related
After tests show they have a high chance of developing cancer, more and more women are choosing drastic surgery in the hope of saving their lives
The article touches on personal perspectives of women affected by BRCA gene mutations, whilst also carrying heavy quotes and references to Eve Appeal funded research programmes.
Every year, 21,000 women in the UK develop a gynaecological cancer. Yet it seems we’re still a nation too shy to speak up, with a fifth of women feeling unable to speak to their GP about their symptoms.
This is why women’s charity The Eve Appeal and the beauty industry’s Cosmetic Executive Women (CEW) have joined forces to launch Get Lippy. The campaign, which aims to raise awareness of gynaecological cancers, runs throughout May, and is backed by top beauty retailers such as Space NK, Harvey Nichols, Tesco and Oliver Bonas, and brands including Elemis, Vaseline, Hourglass, Eos, Lipstick Queen, Bali Balm and Smashbox.
ONE in three women are putting their lives at risk by ignoring the signs of cancer, it's emerged as a new campaign #GetLippy launches aimed at breaking down taboos.
In the UK some 58 women are diagnosed with a gynaecological cancer each day, that's 21,000 women a year. Of those, about 21 women die every day.
Women’s cancer charity, The Eve Appeal, is launching its #GetLippy campaign to encourage women and men to speak up and out about gynaecological health by sharing a ‘pout and shout’ selfie on social media.
The campaign is also calling on the UK to donate or purchase a lipstick from a #GetLippy beauty partner to help raise vital funds for Eve Appeal’s pioneering research, to save women’s lives through early detection, risk-prediction and prevention of all 5 gynaecological cancers.
More than 21,000 women are diagnosed with a form of gynaecological cancer each year in the UK and 21 women will die each day as a result. But only one in seven women can name a single type.
To break the taboos and raise awareness of signs and symptoms, The Eve Appeal is launching a new campaign called Get Lippy. And yes, that means ‘lippy’ in the sense of speaking up about all things gynae, but it also means lipstick! The Eve Appeal has partnered with national retailers, including Tesco, and beauty brands so you can buy a lipstick or lip balm and contribute to pioneering research for screening and interventions.
Research which was funded by The Eve Appeal suggests that more than 80,000 cases of cancer could be prevented if ALL woman over the age of 30 were offered screening for gene mutations.
Woman carrying the ‘BRCA’ gene are much more likely to develop breast or ovarian cancer. Researchers in London have found that screening the entire population for the gene could also be more cost-effective.
Offering every woman over 30 a test for cancer-causing gene mutations could prevent tens of thousands of ovarian and breast cancer cases, scientists say. Public health chiefs said they would look “with interest” at a study showing that national genetic screening would save lives and be cost-effective.
Researcher funded by The Eve Appeal was carried out by a team from Barts Cancer Institute at Queen Mary University of London and Barts Health NHS Trust, calculated that if 71 per cent of women took up the £175 test, up to 17,000 ovarian cancers and 64,000 breast cancers could be prevented.
Eve Appeal funded research has shown that testing all women over 30 for genetic mutations could save more than 80,000 from getting cancer breast or ovarian cancer. The faults, such as the BRCA gene mutation famously carried by Angelina Jolie, significantly raise cancer risk.
But experts at Barts Cancer Institute in London have calculated that if all 26million British women over 30 were tested, 64,500 would be spared breast cancer they would otherwise develop at some stage.
All British women over the age of 30 should be tested for breast and ovarian cancer gene mutations to help save lives and cut costs, new research funded by The Eve Appeal suggests.
Researchers from Barts Cancer Institute at Queen Mary University of London said screening the entire population rather than just those at high-risk of carrying either a BRCA1 or BRCA2 gene mutation would be more cost effective and could help prevent more of the cancers.
